Smith & Nephew’s BIRMINGHAM HIP Resurfacing (S&N BHR) product is a world leader
in innovative orthopaedic treatment. The BHR provides an alternative to total hip
replacement for patients suffering from abnormalities of the hip, including
osteoarthritis, and has found critical acclaim worldwide. The BHR product is approved
by the FDA for use in the Unites States of America and is recognized as the leading hip
resurfacing product globally. With a forecasted 100 per cent year-on-year growth, S&N
UK needed to revise its legacy Quality Management System (QMS) to cope with its
success. Following a review of available QMS products, S&N UK chose an automated
solution from Proquis that has delivered a return on investment in 12 months.
Read the Full Case Study (PDF Document)